The Implications of Pulmonary Embolism in a Multiorgan Donor for Subsequent Pulmonary, Renal, and Cardiac Transplantation

Journal of Heart and Lung Transplantation

Volumn 27, Issue 1, 2008, Pages 78-85

  Oto, Takahiro ^a,c   Excell, Lee ^b   Griffiths, Anne P ^a   Levvey, Bronwyn J ^a   Snell, Gregory I ^a  

^a MONASH UNIVERSITY   (Australia)

^b Australia and New Zealand Dialysis and Transplant Registry   (Australia)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT DYSFUNCTION; HEART TRANSPLANTATION; HUMAN; KIDNEY TRANSPLANTATION; LUNG EMBOLISM; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PRIORITY JOURNAL; PULMONARY ARTERY;

ADULT; EMBOLECTOMY; FEMALE; HEART TRANSPLANTATION; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW ZEALAND; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PULMONARY EMBOLISM; RISK FACTORS;

EID: 37548999380     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.10.001     Document Type: Article

References (24)

1. Cecka J.M. The OPTN/UNOS renal transplant registry. Clin Transpl (2004) 1-16
2. Potapov E.V., Ivanitskaia E.A., Loebe M., et al. Value of cardiac troponin I and T for selection of heart donors and as predictors of early graft failure. Transplantation 71 (2001) 1394-1400
3. Lima B., Rajagopal K., Petersen R.P., et al. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. Circulation 114 (2006) 127-132
4. Christie J.D., Kotloff R.M., Pochettino A., et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 124 (2003) 1232-1241
5. Oto T., Rabinov M., Griffiths A.P., et al. Unexpected donor pulmonary embolism affects early outcomes after lung transplantation: A major mechanism of primary graft failure?. J Thorac Cardiovasc Surg 130 (2005) 1446-1452
6. Forrest A.P., and Sutton B. Massive intraoperative pulmonary embolism: it may not be as bad as it looks. Anaesth Intensive Care 34 (2006) 510-513
7. Husebye E.E., Lyberg T., and Roise O. Bone marrow fat in the circulation: clinical entities and pathophysiological mechanisms. Injury 37 (2006) 8-18
8. Sevitt S. The significance and pathology of fat embolism. Ann Clin Res 9 (1977) 173-180
9. Stewart S., Ciulli F., Wells F.C., and Wallwork J. Pathology of unused donor lungs. Transplant Proc 25 (1993) 1167-1168
10. Ware L.B., Fang X., Wang Y., Babcock W.D., Jones K., and Matthay M.A. High prevalence of pulmonary arterial thrombi in donor lungs rejected for transplantation. J Heart Lung Transplant 24 (2005) 1650-1656
11. Christie J.D., Carby M., Bag R., Corris P., Hertz M., and Well D. Report of the ISHLT working group on primary lung graft dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 24 (2005) 1454-1459
12. Oto T., Levvey B.J., and Snell G.I. Potential refinements of the International Society for Heart and Lung Transplantation Primary Graft Dysfunction Grading System. J Heart Lung Transplant 26 (2007) 431-436
13. McDonald S., Russ G., Campbell S., and Chadban S. Kidney transplant rejection in Australia and New Zealand: relationships between rejection and graft outcome. Am J Transplant 7 (2007) 1201-1208
14. Baker P.L., Pazell J.A., and Peltier L.F. Free fatty acids, catecholamines, and arterial hypoxia in patients with fat embolism. J Trauma 11 (1971) 1026-1030
15. Schult M.F.U., Schiedel F., Brug E., et al. Pathophysiology of fat embolism after intramedullary reaming. J Trauma 29 (2003) 68-73
16. Jacobovitz-Derks D., and Derks C.M. Pulmonary neutral fat embolism in dogs. Am J Pathol 95 (1979) 29-42
17. Frenia D., Nathan S.D., Ahmad S., et al. Successful lung transplantation from a donor with a saddle pulmonary embolus. J Heart Lung Transplant 24 (2005) 1137-1139
18. Fischer S., Gohrbandt B., Meyer A., Simon A.R., Haverich A., and Stru″ber M. Should lungs from donors with severe acute pulmonary embolism be accepted for transplantation? The Hannover experience. J Thorac Cardiovasc Surg 126 (2003) 1641-1643
19. Venuta F., Rendina E.A., Bufi M., et al. Preimplantation retrograde pneumoplegia in clinical lung transplantation. J Thorac Cardiovasc Surg 118 (1999) 107-114
20. de Perrot, and Keshavjee S. Lung preservation. Semin Thorac Cardiovasc Surg 16 (2005) 300-308
21. Higuchi T., Oto T., Zheng L., et al. Elevated IL-8 levels in retrograde flush effluent is associated with unexpected donor pulmonary embolism: a novel predictor for primary graft dysfunction?. J Heart Lung Transplant 26 (2007) S170
22. de Perrot M., Fischer S., Liu M., et al. Prostaglandin E1 protects lung transplants from ischemia-reperfusion injury: a shift from pro- to anti-inflammatory cytokines. Transplantation 72 (2001) 1505-1512
23. Keshavjee S., Davis R.D., Zamora M.R., de Perrot M., and Patterson G.A. A randomized, placebo controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings. J Thorac Cardiovasc Surg 129 (2005) 423-428
24. Wittwer T., Grote M., Oppelt P., Franke U., Schaefers H.J., and Wahlers T. Impact of PAF antagonist BN 52021 (Ginkolide B) on post-ischemic graft function in clinical lung transplantation. J Heart Lung Transplant 20 (2001) 358-363